Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04436822 · ClinicalTrials.gov registry record · NA
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
A NA study of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, sponsored by Medtronic Diabetes.
- Completed
- Registry status
- NA
- Development phase
- 317
- Enrollment target
- 18
- Study locations
NCT04436822 is a NA study of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus that has completed, run by Medtronic Diabetes. The registered enrollment target is 317 participants, below the 2,746-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (88% lower). The trial reports 18 study locations across 13 states.
The verdict
NCT04436822, a NA study of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, has completed, sponsored by Medtronic Diabetes.
- COMPLETED
- Registry status
- NA
- Development phase
- 317 participants
- Enrollment target
- 18
- Study locations
Study Summary
The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitoring
Study Locations (18)
California
- AMCR Institute - Escondido
- Sansum Diabetes Research Institute - Santa Barbara
- SoCal Diabetes - Torrance
- Diablo Clinical Research, Inc. - Walnut Creek
Colorado
- Barbara Davis Center for Childhood Diabetes - Aurora
- Barbara Davis Center for Diabetes - Aurora
Shanghai Municipality
- Shanghai Sixth People's Hospital - Shanghai
- Children's Hospital of Fudan University - Shanghai
Florida
- University of South Florida - Tampa
Georgia
- Atlanta Diabetes Associates - Atlanta
Idaho
- Rocky Mountain Diabetes and Osteoporosis Center - Idaho Falls
Tennessee
- AM Diabetes and Endocrinology Center - Bartlett
Texas
- Texas Diabetes & Endocrinology - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2022-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04436822
The ClinicalTrials.gov registry entry for NCT04436822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,746-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (88% lower). The listed sponsor is Medtronic Diabetes, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.
NCT04436822 reports 18 study locations spanning 13 distinct geographic areas - top geographies include California, Colorado, Shanghai Municipality.
Frequently Asked Questions
What is clinical trial NCT04436822 about?
NCT04436822 is a clinical study titled "Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics". The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).
What is the current status of trial NCT04436822?
This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2020-07-15. Estimated completion is 2022-04-12.
What conditions does trial NCT04436822 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT04436822?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT04436822?
This trial is sponsored by Medtronic Diabetes, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04436822 being conducted?
This trial has 18 study locations across California, Colorado, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
RECRUITING · NA
-
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
ACTIVE NOT RECRUITING · NA
-
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.